Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

An integrated expression atlas of miRNAs and their promoters in human and mouse.

de Rie D, Abugessaisa I, Alam T, Arner E, Arner P, Ashoor H, Åström G, Babina M, Bertin N, Burroughs AM, Carlisle AJ, Daub CO, Detmar M, Deviatiiarov R, Fort A, Gebhard C, Goldowitz D, Guhl S, Ha TJ, Harshbarger J, Hasegawa A, Hashimoto K, Herlyn M, Heutink P, Hitchens KJ, Hon CC, Huang E, Ishizu Y, Kai C, Kasukawa T, Klinken P, Lassmann T, Lecellier CH, Lee W, Lizio M, Makeev V, Mathelier A, Medvedeva YA, Mejhert N, Mungall CJ, Noma S, Ohshima M, Okada-Hatakeyama M, Persson H, Rizzu P, Roudnicky F, Sætrom P, Sato H, Severin J, Shin JW, Swoboda RK, Tarui H, Toyoda H, Vitting-Seerup K, Winteringham L, Yamaguchi Y, Yasuzawa K, Yoneda M, Yumoto N, Zabierowski S, Zhang PG, Wells CA, Summers KM, Kawaji H, Sandelin A, Rehli M; FANTOM Consortium, Hayashizaki Y, Carninci P, Forrest ARR, de Hoon MJL.

Nat Biotechnol. 2017 Sep;35(9):872-878. doi: 10.1038/nbt.3947. Epub 2017 Aug 21.

2.

Antimelanoma CTL recognizes peptides derived from an ORF transcribed from the antisense strand of the 3' untranslated region of TRIT1.

Swoboda RK, Somasundaram R, Caputo-Gross L, Marincola FM, Robbins P, Herlyn M, Herlyn D.

Mol Ther Oncolytics. 2015 Jan 14;1:14009. doi: 10.1038/mto.2014.9. eCollection 2015.

3.

A promoter-level mammalian expression atlas.

FANTOM Consortium and the RIKEN PMI and CLST (DGT), Forrest AR, Kawaji H, Rehli M, Baillie JK, de Hoon MJ, Haberle V, Lassmann T, Kulakovskiy IV, Lizio M, Itoh M, Andersson R, Mungall CJ, Meehan TF, Schmeier S, Bertin N, Jørgensen M, Dimont E, Arner E, Schmidl C, Schaefer U, Medvedeva YA, Plessy C, Vitezic M, Severin J, Semple C, Ishizu Y, Young RS, Francescatto M, Alam I, Albanese D, Altschuler GM, Arakawa T, Archer JA, Arner P, Babina M, Rennie S, Balwierz PJ, Beckhouse AG, Pradhan-Bhatt S, Blake JA, Blumenthal A, Bodega B, Bonetti A, Briggs J, Brombacher F, Burroughs AM, Califano A, Cannistraci CV, Carbajo D, Chen Y, Chierici M, Ciani Y, Clevers HC, Dalla E, Davis CA, Detmar M, Diehl AD, Dohi T, Drabløs F, Edge AS, Edinger M, Ekwall K, Endoh M, Enomoto H, Fagiolini M, Fairbairn L, Fang H, Farach-Carson MC, Faulkner GJ, Favorov AV, Fisher ME, Frith MC, Fujita R, Fukuda S, Furlanello C, Furino M, Furusawa J, Geijtenbeek TB, Gibson AP, Gingeras T, Goldowitz D, Gough J, Guhl S, Guler R, Gustincich S, Ha TJ, Hamaguchi M, Hara M, Harbers M, Harshbarger J, Hasegawa A, Hasegawa Y, Hashimoto T, Herlyn M, Hitchens KJ, Ho Sui SJ, Hofmann OM, Hoof I, Hori F, Huminiecki L, Iida K, Ikawa T, Jankovic BR, Jia H, Joshi A, Jurman G, Kaczkowski B, Kai C, Kaida K, Kaiho A, Kajiyama K, Kanamori-Katayama M, Kasianov AS, Kasukawa T, Katayama S, Kato S, Kawaguchi S, Kawamoto H, Kawamura YI, Kawashima T, Kempfle JS, Kenna TJ, Kere J, Khachigian LM, Kitamura T, Klinken SP, Knox AJ, Kojima M, Kojima S, Kondo N, Koseki H, Koyasu S, Krampitz S, Kubosaki A, Kwon AT, Laros JF, Lee W, Lennartsson A, Li K, Lilje B, Lipovich L, Mackay-Sim A, Manabe R, Mar JC, Marchand B, Mathelier A, Mejhert N, Meynert A, Mizuno Y, de Lima Morais DA, Morikawa H, Morimoto M, Moro K, Motakis E, Motohashi H, Mummery CL, Murata M, Nagao-Sato S, Nakachi Y, Nakahara F, Nakamura T, Nakamura Y, Nakazato K, van Nimwegen E, Ninomiya N, Nishiyori H, Noma S, Noma S, Noazaki T, Ogishima S, Ohkura N, Ohimiya H, Ohno H, Ohshima M, Okada-Hatakeyama M, Okazaki Y, Orlando V, Ovchinnikov DA, Pain A, Passier R, Patrikakis M, Persson H, Piazza S, Prendergast JG, Rackham OJ, Ramilowski JA, Rashid M, Ravasi T, Rizzu P, Roncador M, Roy S, Rye MB, Saijyo E, Sajantila A, Saka A, Sakaguchi S, Sakai M, Sato H, Savvi S, Saxena A, Schneider C, Schultes EA, Schulze-Tanzil GG, Schwegmann A, Sengstag T, Sheng G, Shimoji H, Shimoni Y, Shin JW, Simon C, Sugiyama D, Sugiyama T, Suzuki M, Suzuki N, Swoboda RK, 't Hoen PA, Tagami M, Takahashi N, Takai J, Tanaka H, Tatsukawa H, Tatum Z, Thompson M, Toyodo H, Toyoda T, Valen E, van de Wetering M, van den Berg LM, Verado R, Vijayan D, Vorontsov IE, Wasserman WW, Watanabe S, Wells CA, Winteringham LN, Wolvetang E, Wood EJ, Yamaguchi Y, Yamamoto M, Yoneda M, Yonekura Y, Yoshida S, Zabierowski SE, Zhang PG, Zhao X, Zucchelli S, Summers KM, Suzuki H, Daub CO, Kawai J, Heutink P, Hide W, Freeman TC, Lenhard B, Bajic VB, Taylor MS, Makeev VJ, Sandelin A, Hume DA, Carninci P, Hayashizaki Y.

Nature. 2014 Mar 27;507(7493):462-70. doi: 10.1038/nature13182.

4.

Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma.

Villanueva J, Infante JR, Krepler C, Reyes-Uribe P, Samanta M, Chen HY, Li B, Swoboda RK, Wilson M, Vultur A, Fukunaba-Kalabis M, Wubbenhorst B, Chen TY, Liu Q, Sproesser K, DeMarini DJ, Gilmer TM, Martin AM, Marmorstein R, Schultz DC, Speicher DW, Karakousis GC, Xu W, Amaravadi RK, Xu X, Schuchter LM, Herlyn M, Nathanson KL.

Cell Rep. 2013 Sep 26;4(6):1090-9. doi: 10.1016/j.celrep.2013.08.023. Epub 2013 Sep 19.

5.

There is a world beyond protein mutations: the role of non-coding RNAs in melanomagenesis.

Swoboda RK, Herlyn M.

Exp Dermatol. 2013 May;22(5):303-6. doi: 10.1111/exd.12117. Epub 2013 Mar 12.

6.

Nucleophosmin is recognized by a cytotoxic T cell line derived from a rectal carcinoma patient.

Swoboda RK, Somasundaram R, Caputo L, Berencsi K, von Franzke P, Taylor DD, Marincola FM, Meropol NJ, Sigurdson E, Miller E, Herlyn D.

Int J Cancer. 2010 Sep 1;127(5):1124-30. doi: 10.1002/ijc.25133.

7.

Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage display.

Swoboda RK, Somasundaram R, Caputo L, Ochoa EM, Gimotty PA, Marincola FM, Van Belle P, Barth S, Elder D, Guerry D, Czerniecki B, Schuchter L, Vonderheide RH, Herlyn D.

Cancer Res. 2007 Apr 15;67(8):3555-9.

8.

Sec20p-interacting proteins (Tip20p, Ufe1p) in the retrograde secretory pathway of the fungal pathogen Candida albicans.

Weber Y, Swoboda RK, Ernst JF.

Mol Genet Genomics. 2002 Dec;268(4):468-76. Epub 2002 Nov 16.

PMID:
12471444
9.

A comprehensive study of Candida-specific antibodies in the saliva of human immunodeficiency virus-positive individuals with oropharyngeal candidiasis.

Wozniak KL, Leigh JE, Hager S, Swoboda RK, Fidel PL Jr.

J Infect Dis. 2002 May 1;185(9):1269-76. Epub 2002 Apr 16.

PMID:
12001044
10.

Th1/Th2 cytokine profiles in saliva of HIV-positive smokers with oropharyngeal candidiasis.

Slavinsky J 3rd, Myers T, Swoboda RK, Leigh JE, Hager S, Fidel PL Jr.

Oral Microbiol Immunol. 2002 Feb;17(1):38-43.

PMID:
11860554
11.

Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis.

Leigh JE, Barousse M, Swoboda RK, Myers T, Hager S, Wolf NA, Cutright JL, Thompson J, Sobel JD, Fidel PL Jr.

J Infect Dis. 2001 Jan 15;183(2):277-285. Epub 2000 Dec 13.

PMID:
11120933
13.

Cytoskeletal proteins and morphogenesis in Candida albicans and Yarrowia lipolytica.

Kurischko C, Swoboda RK.

Contrib Microbiol. 2000;5:173-84. Review. No abstract available.

PMID:
10863672
14.

Sequence analysis of SLA2 of the dimorphic yeasts Candida albicans and Yarrowia lipolytica.

Melms AS, Gausmann U, Swoboda RK, Dominguez A, Kurischko C.

Yeast. 1999 Oct;15(14):1519-28.

15.

Structure and regulation of the Candida albicans ADH1 gene encoding an immunogenic alcohol dehydrogenase.

Bertram G, Swoboda RK, Gooday GW, Gow NA, Brown AJ.

Yeast. 1996 Feb;12(2):115-27.

16.

Structure and regulation of the Hsp90 gene from the pathogenic fungus Candida albicans.

Swoboda RK, Bertram G, Budge S, Gooday GW, Gow NA, Brown AJ.

Infect Immun. 1996 Feb;64(2):680. No abstract available.

17.

Structure and regulation of the HSP90 gene from the pathogenic fungus Candida albicans.

Swoboda RK, Bertram G, Budge S, Gooday GW, Gow NA, Brown AJ.

Infect Immun. 1995 Nov;63(11):4506-14. Erratum in: Infect Immun. 1996 Feb;64(2):680.

18.

Structure and regulation of a Candida albicans RP10 gene which encodes an immunogenic protein homologous to Saccharomyces cerevisiae ribosomal protein 10.

Swoboda RK, Broadbent ID, Bertram G, Budge S, Gooday GW, Gow NA, Brown AJ.

J Bacteriol. 1995 Mar;177(5):1239-46.

19.

Regulation of the gene encoding translation elongation factor 3 during growth and morphogenesis in Candida albicans.

Swoboda RK, Bertram G, Colthurst DR, Tuite MF, Gow NA, Gooday GW, Brown AJ.

Microbiology. 1994 Oct;140 ( Pt 10):2611-6.

PMID:
8000530
20.

Fluctuations in glycolytic mRNA levels during morphogenesis in Candida albicans reflect underlying changes in growth and are not a response to cellular dimorphism.

Swoboda RK, Bertram G, Delbrück S, Ernst JF, Gow NA, Gooday GW, Brown AJ.

Mol Microbiol. 1994 Aug;13(4):663-72.

PMID:
7997178
21.

Glycolytic enzymes of Candida albicans are nonubiquitous immunogens during candidiasis.

Swoboda RK, Bertram G, Hollander H, Greenspan D, Greenspan JS, Gow NA, Gooday GW, Brown AJ.

Infect Immun. 1993 Oct;61(10):4263-71.

22.

Codon utilisation in the pathogenic yeast, Candida albicans.

Brown AJ, Bertram G, Feldmann PJ, Peggie MW, Swoboda RK.

Nucleic Acids Res. 1991 Aug 11;19(15):4298. No abstract available.

Supplemental Content

Loading ...
Support Center